Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients

Abstract The purpose of this study is to evaluate the levels and clinical diagnosis value of CA15-3, CEA, and SF in canine mammary gland tumors (CMGTs). In this study, the levels of tissues/serum CA15-3, CEA, and SF in 178 CMGT patients or healthy dogs were determined by ELISA and qRT-PCR assay. CA1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuying Fan, Xiaoli Ren, Xuesong Liu, Dongmei Shi, Enshuang Xu, Shuang Wang, Yun Liu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3fe16fe04ee14a4a9ab29e7112d87c30
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3fe16fe04ee14a4a9ab29e7112d87c30
record_format dspace
spelling oai:doaj.org-article:3fe16fe04ee14a4a9ab29e7112d87c302021-12-02T13:24:25ZCombined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients10.1038/s41598-021-85029-42045-2322https://doaj.org/article/3fe16fe04ee14a4a9ab29e7112d87c302021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85029-4https://doaj.org/toc/2045-2322Abstract The purpose of this study is to evaluate the levels and clinical diagnosis value of CA15-3, CEA, and SF in canine mammary gland tumors (CMGTs). In this study, the levels of tissues/serum CA15-3, CEA, and SF in 178 CMGT patients or healthy dogs were determined by ELISA and qRT-PCR assay. CA15-3, CEA, and SF levels of the malignant tumor group were significantly higher than that of the benign tumor group and the healthy control group. In the malignant tumor group, CA15-3 held a sensitivity of 51.8%, a specificity of 93.9%, and an accuracy of 76.8%. The sensitivity, specificity, and accuracy of CEA were 44.6%, 84.1%, and 68.1% respectively. SF held a sensitivity of 62.5%, a specificity of 85.4%, and an accuracy of 76.1%. SF showed the highest sensitivity and CA15-3 showed the highest specificity. The sensitivity, specificity, and accuracy of the combined detection of the three biomarkers in malignant tumor groups were 80.4%, 78.0%, and 80.0%, respectively, therefore combined detection increased sensitivity and accuracy but decreased specificity. In conclusion, the combined detection of serum/tissue markers CA15-3, CEA, and SF may improve the detection sensitivity of CMGTs, providing reference value for clinical application.Yuying FanXiaoli RenXuesong LiuDongmei ShiEnshuang XuShuang WangYun LiuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yuying Fan
Xiaoli Ren
Xuesong Liu
Dongmei Shi
Enshuang Xu
Shuang Wang
Yun Liu
Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
description Abstract The purpose of this study is to evaluate the levels and clinical diagnosis value of CA15-3, CEA, and SF in canine mammary gland tumors (CMGTs). In this study, the levels of tissues/serum CA15-3, CEA, and SF in 178 CMGT patients or healthy dogs were determined by ELISA and qRT-PCR assay. CA15-3, CEA, and SF levels of the malignant tumor group were significantly higher than that of the benign tumor group and the healthy control group. In the malignant tumor group, CA15-3 held a sensitivity of 51.8%, a specificity of 93.9%, and an accuracy of 76.8%. The sensitivity, specificity, and accuracy of CEA were 44.6%, 84.1%, and 68.1% respectively. SF held a sensitivity of 62.5%, a specificity of 85.4%, and an accuracy of 76.1%. SF showed the highest sensitivity and CA15-3 showed the highest specificity. The sensitivity, specificity, and accuracy of the combined detection of the three biomarkers in malignant tumor groups were 80.4%, 78.0%, and 80.0%, respectively, therefore combined detection increased sensitivity and accuracy but decreased specificity. In conclusion, the combined detection of serum/tissue markers CA15-3, CEA, and SF may improve the detection sensitivity of CMGTs, providing reference value for clinical application.
format article
author Yuying Fan
Xiaoli Ren
Xuesong Liu
Dongmei Shi
Enshuang Xu
Shuang Wang
Yun Liu
author_facet Yuying Fan
Xiaoli Ren
Xuesong Liu
Dongmei Shi
Enshuang Xu
Shuang Wang
Yun Liu
author_sort Yuying Fan
title Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
title_short Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
title_full Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
title_fullStr Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
title_full_unstemmed Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
title_sort combined detection of ca15-3, cea, and sf in serum and tissue of canine mammary gland tumor patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3fe16fe04ee14a4a9ab29e7112d87c30
work_keys_str_mv AT yuyingfan combineddetectionofca153ceaandsfinserumandtissueofcaninemammaryglandtumorpatients
AT xiaoliren combineddetectionofca153ceaandsfinserumandtissueofcaninemammaryglandtumorpatients
AT xuesongliu combineddetectionofca153ceaandsfinserumandtissueofcaninemammaryglandtumorpatients
AT dongmeishi combineddetectionofca153ceaandsfinserumandtissueofcaninemammaryglandtumorpatients
AT enshuangxu combineddetectionofca153ceaandsfinserumandtissueofcaninemammaryglandtumorpatients
AT shuangwang combineddetectionofca153ceaandsfinserumandtissueofcaninemammaryglandtumorpatients
AT yunliu combineddetectionofca153ceaandsfinserumandtissueofcaninemammaryglandtumorpatients
_version_ 1718393089129709568